Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $945.66 million. The enterprise value is $781.86 million.

Market Cap	945.66M
Enterprise Value	781.86M

Important Dates

The last earnings date was Monday, May 5, 2025, after market close.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

SNDX has 86.05 million shares outstanding. The number of shares has increased by 15.54% in one year.

Current Share Class	86.05M
Shares Outstanding	86.05M
Shares Change (YoY)	+15.54%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	95.75%
Float	76.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.01
Forward PS	7.87
PB Ratio	4.28
P/TBV Ratio	4.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.80, with a Debt / Equity ratio of 1.61.

Current Ratio	5.80
Quick Ratio	5.69
Debt / Equity	1.61
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.59

Financial Efficiency

Return on equity (ROE) is -93.70% and return on invested capital (ROIC) is -40.76%.

Return on Equity (ROE)	-93.70%
Return on Assets (ROA)	-36.29%
Return on Invested Capital (ROIC)	-40.76%
Return on Capital Employed (ROCE)	-62.92%
Revenue Per Employee	$161,933
Profits Per Employee	-$1.23M
Employee Count	270
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.47% in the last 52 weeks. The beta is 0.82, so SNDX's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-49.47%
50-Day Moving Average	12.63
200-Day Moving Average	16.13
Relative Strength Index (RSI)	41.30
Average Volume (20 Days)	2,379,893

Short Selling Information

The latest short interest is 21.66 million, so 25.17% of the outstanding shares have been sold short.

Short Interest	21.66M
Short Previous Month	21.17M
Short % of Shares Out	25.17%
Short % of Float	28.14%
Short Ratio (days to cover)	11.32

Income Statement

In the last 12 months, SNDX had revenue of $43.72 million and -$331.20 million in losses. Loss per share was -$3.86.

Revenue	43.72M
Gross Profit	-199.64M
Operating Income	-343.67M
Pretax Income	-264.08M
Net Income	-331.20M
EBITDA	-343.66M
EBIT	-343.67M
Loss Per Share	-$3.86

Full Income Statement

Balance Sheet

The company has $516.31 million in cash and $345.63 million in debt, giving a net cash position of $170.68 million or $1.98 per share.

Cash & Cash Equivalents	516.31M
Total Debt	345.63M
Net Cash	170.68M
Net Cash Per Share	$1.98
Equity (Book Value)	215.06M
Book Value Per Share	2.50
Working Capital	454.20M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-286.52M
Capital Expenditures	n/a
Free Cash Flow	-286.52M
FCF Per Share	-$3.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-786.03%
Pretax Margin	-757.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.54%
Shareholder Yield	-15.54%
Earnings Yield	-34.77%
FCF Yield	-30.08%

Dividend Details

Analyst Forecast

The average price target for SNDX is $35.91, which is 226.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.91
Price Target Difference	226.75%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	94.20%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNDX has an Altman Z-Score of -1.51 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.51
Piotroski F-Score	1